UK drug update - November 2004

Published: 1-Nov-2004
Regulatory


Trinity Pharmaceuticals has brought out Cardioplen XL. The 5mg and 10mg tablets contain the class II calcium antagonist felodipine.

Almus has made available 75mg tablets and 25mg capsules of the tricyclic antidepressant dosulepin hydrochloride (previously called dothiepin). The company has also brought out 10mg, 20mg and 40mg tablets of the statin prava-statin sodium.

LPC Pharmaceuticals has launched 200mg tablets of the folic acid inhibitor trimethoprim.

Denfleet Pharmaceuticals has started marketing Denzapine, containing 25mg or 100mg of the dibenzo-diazepine clozapine.

Sandoz has introduced Acnocin (co-cyprindiol). The tablets contain 2000µg of the antiandrogen cyproterone acetate and 35µg of the oestrogen ethinyl-oestradiol.

Almus Pharmaceuticals has launched 2mg, 5mg and 10mg tablets of the benzodiazepine diazepam.

Nycomed has made available TachoSil medicated sponge. The product contains human fibrinogen 5.5mg/cm2 and human thrombin 2 IU/cm2.

Beacon Pharmaceuticals has marketed gentamicin intrathecal solution for injection, containing 5mg/mL of the aminoglycoside gentamicin.

Novartis has introduced Glivec tablets containing 100mg of the Bcr-Abl tyrosine kinase inhibitor imatinib. The company has also manufactured Myfortic tablets containing 180mg or 360mg of the immunosuppressant mycophenolic acid, as mycophenolate sodium.

Sandoz has brought out 100mg capsules of the triazole antifungal itraconazole.

Pfizer has made available Lyrica capsules to the primary care market (previously they were only available through hospitals). The capsules contain 25mg, 75mg, 150mg or 300mg (56 capsule pack) or 25mg, 50mg, 100mg or 200mg (84 capsule pack) of the GABA analogue pregabalin.

See more

You may also like

Manufacturing

Signal Group launches MCERTS approved VOC emissions monitor

Read more
New SOLAR CEMNEX analyser offers advanced compliance and connectivity features

Trending Articles

  1. Douglas Pharmaceuticals sets new benchmark for capsule quality with CI Precision Partnership delivers compliance confidence, efficiency gains and reduced waste
  2. Balancing innovation and accessibility in amino acid testing Butterworth Laboratories expands analytical capabilities to support compliance with Ph. Eur. standards
  3. You need to be a subscriber to read this article.
    Click here to find out more.
    Quality management during manufacturing changes: part I Change is a universal constant and continues to accelerate in the realms of pharmaceutical, medical device and in-vitro diagnostic manufacturers who face ever-increasing pressure to optimise costs while maintaining high product quality and patient safety standards
  4. NICE recommends enfortumab vedotin with KEYTRUDA for adults in England/Wales with untreated metastatic urothelial cancer The results from the Phase III study EV-302/KN-A39 showed nearly a doubling of survival rates in patients compared with those who received platinum-based chemotherapy, which is the current standard of care in the UK
  5. FDA makes groundbreaking decision to waive clinical efficiency studies for monoclonal antibody biosimilars The University of Illinois secured the first-ever FDA acceptance to waive clinical efficiency studies (CESs) for the biological drugs

Upcoming event

Enhancing probiotic stability through smarter formulation and packaging strategies

18 September 2025 | Virtual See all

You may also like

Manufacturing

Signal Group launches MCERTS approved VOC emissions monitor

New SOLAR CEMNEX analyser offers advanced compliance and connectivity features
You need to be a subscriber to read this article.
Click here to find out more.
Packaging

Cloud labelling and serialisation: the new frontline of traceability in drug delivery

As drug delivery evolves to accommodate a new wave of data-driven innovation, the need for traceability and compliance throughout the supply chain is paramount. Innovative cloud-based solutions enable pharmaceutical companies to navigate these demands with confidence
Regulatory

Novo Nordisk’s oral semaglutide scores EU approval for cardiovascular benefits

Rybelsus is now the first and only oral GLP-1 RA to reduce cardiovascular death, heart attack and stroke
Manufacturing

Douglas Pharmaceuticals sets new benchmark for capsule quality with CI Precision

Partnership delivers compliance confidence, efficiency gains and reduced waste
Regulatory

New NICE thresholds: good news for rare disease drugs but process remains complex

Recent changes introduced by NICE will ultimately see more ultra-rare disease drugs get to market, but Dan Williams, CEO at SynaptixBio, says the process remains challenging
Manufacturing

Balancing innovation and accessibility in amino acid testing

Butterworth Laboratories expands analytical capabilities to support compliance with Ph. Eur. standards
You need to be a subscriber to read this article.
Click here to find out more.
Manufacturing

Quality management during manufacturing changes: part I

Change is a universal constant and continues to accelerate in the realms of pharmaceutical, medical device and in-vitro diagnostic manufacturers who face ever-increasing pressure to optimise costs while maintaining high product quality and patient safety standards
Subscribe now